Helicobacter Pylori Testing Market Size By Test Type (Invasive {Histology, Rapid Urease Test (RUT), HP Culture}, Non-Invasive {Serologic Test, Urea Breath Test (UBT), Stool Antigen Test (SAT)}), By Method (Point-of-care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Oct 2019  |  Report ID: GMI4408  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 180   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry trends

Helicobacter Pylori Testing Market size exceeded $340 Million in 2018 and is poised to register over 7.5% CAGR up to 2025.
 

Helicobacter Pylori Testing Market

Get more details on this report - Request Free Sample PDF
 

Helicobacter pylori (H. pylori) is an aerobic, gram-negative bacteria primarily detected in the stomach. It plays a vital role in sustaining the stomach ecosystem. H. pylori infection is caused when spiral-shaped bacteria attacks oesophagus, small intestine & stomach lining that lead to gastric cancer, peptic ulcers, and chronic gastritis. According to the National Institute of Health, globally about 80% of adults & 10% of children are prone to have H. pylori infection. To detect the infection, different types of test such as breath test, stool antigen test, tissue biopsy, etc. are available in the market. Furthermore, various newer tests are under different development stages. Hence, introduction of new innovative tests will augment the market progress.
 

According to the WHO, more than half of global populace carries H. pylori contributing it to become the third prominent cause of cancer-associated deaths. In 1994, the WHO’s International Agency for Research for Cancer (IARC) classified H. Pylori as a Class 1 carcinogen. The occurrence of this bacteria in developing countries is among the highest in the globe, underlining demand for a very precise and easy to administer test. Recent technological advances in urea breath test used for detection of enzyme produced by H. pylori testing is swiftly evolving medical research and is estimated to transmute healthcare approach in the near future.
 

The industry will witness an influx of new and private players offering innovative and affordable coverage in future. Also, industry players are investing immensely in R&D processes to offer distinguished solutions and gain competitive advantage. Developed countries are implementing non-invasive methodologies in numerous areas of healthcare. In addition, various government organizations are putting efforts to create awareness in public regarding H. Pylori infection will propel growth of market in near future.
 

Helicobacter Pylori Testing Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 342.3 Million (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period (2019 to 2025) CAGR: 7.5% 2025 Value Projection: 564.1 Million (USD)
Pages: 180 Tables, Charts & Figures: 171
Geographies covered (23): U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Romania, Russia, Japan, China, India, Australia, South Korea, Brazil, Mexico, Chile, Argentina, South Africa, Saudi Arabia, Nigeria, Turkey
Segments covered: Test Type, Method, End-use and Region
Companies covered (11): Abbott, Avanos Corporate, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Thermo Fisher Scientific, Gulf Coast Scientific, Medline Industries, Inc., Meridian Biosciences, Quidel Corporation
Growth Drivers:
  • Rise in prevalence of gastric ulcer
  • Increasing elderly population in Asia Pacific countries
  • Growing demand for point of care testing devices
  • Rising adoption of non-invasive H. pylori testing
Pitfalls & Challenges:
  • Lack of skilled professionals for invasive testing
  • Lack of awareness regarding H. Pylori infection

Request 15% Free Customization on this Report
 

Gastric ulcers to boom the helicobacter pylori testing market share

In forthcoming years, the market for H. pylori testing will witness a rapid expansion around the globe. The foremost factors that will contribute significantly to development are, increase in geriatric population & growing cases of patients suffering from numerous infectious diseases and gastritis. An approximate one of six entities infected with H. pylori are likely to develop peptic ulcer disorder. Affected individuals suffer long asymptomatic conditions. Among them, almost 70% suffer from minimal symptoms such as burping, vomiting, bloating, nausea, stomach discomfort as occasional, whereas, major symptoms include abdominal & intestinal pain, peptic ulcer, bad breath etc. Increase in prevalence of such symptoms will boost market growth.
 

Nonetheless, as more regions of globe get access to uncontaminated water & sanitation, the frequency of infection will decline, ultimately hampering the growth of testing market. Furthermore, demand for serological tests is declining due to less sensitivity & inaccuracy of test results leading to decline in segmental growth in global market. In addition, lack of awareness regarding H. pylori infection and high cost of biopsy associated diagnostics are likely to obstruct the market expansion during the projected period.
 

Urea breath test to attain new altitudes in helicobacter pylori testing industry

Global Helicobacter Pylori Testing Market Share, By Non-invasive Test Type, 2018
Global Helicobacter Pylori Testing Market Share, By Non-invasive Test Type, 2018

Get more details on this report - Request Free Sample PDF
 

Based on test type, the market is bifurcated into invasive and non-invasive types. Invasive test type is further segmented into histology, rapid urease test (RUT) and HP culture. Non-invasive test type is categorized into serologic test, urea breath test (UBT) and stool antigen test (SAT). The soaring prevalence of infections occurred and awareness against the same is driving the Helicobacter pylori non-invasive testing market. Escalating rate of adoption of enhanced non-invasive technologies coupled with rising number of firms offering innovative testing kits will strengthen market expansion. For instance, urea breath test is gaining popularity for its rapid diagnostics capability, safety and high sensitivity for detecting H. pylori infection in children. In addition, growing number of public & private investments and surge in research grants should drive industry expansion.
 

Point-of-care (POC) continue to dominate the overall market

On the basis of method of test, helicobacter pylori testing market is sectored into point-of-care (POC) test and laboratory-based test. POC test accounted for revenue share of around 120 million in 2018 and may experience high growth opportunities in the market. The POC testing is less expensive and gives accurate results in short time span. The companies operating in the market are focusing on development of advanced diagnostics kits. For instance, in March 2018, Exalenz Bioscience Ltd. received U.S. FDA approval for the BreathID Hp point-of-care system, to detect H. pylori infection in children aged between 3-17 years. The new product development for H. pylori testing is expected to propel the growth of market in coming years. In addition, advent of home diagnostic kits is providing the opportunity for the growth of the market. 
 

Hospitals will aid in boosting evolution of helicobacter pylori testing industry

Based on end-use, H. pylori testing market is segmented into hospitals, clinics, diagnostic laboratories. Among end-use, hospital segment accounted for significant share of more than 30% in 2018. The elderly population base has a high preference towards hospitals due to convenience offered by them to the patients. Moreover, large number of patient pool, and high adoption of new tests and instruments for diagnosis of H. pylori is expected to fuel the growth of hospital end-use segment.
 

High number of market players in the U.S. to boost helicobacter pylori testing industry growth

Asia Pacific Helicobacter Pylori Testing Market, By Country, 2025 (USD Million)
Asia Pacific Helicobacter Pylori Testing Market, By Country, 2025 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Asia Pacific is projected to show lucrative CAGR of more than 8.5% over forecast period. The growth of market in the region is primarily attributed to rising occurrence of gastric cancer in China, Japan and India. For instance, according to the Chinese University of Hong Kong (CUHK), in 2017, over 50% of the Asian populace were affected by H. pylori, impacting to the overall progress of the market. The market in the region is also projected to expand due to intensifying development in biotechnology industry. In addition, the development in testing sectors across these countries are estimated to fuel the growth of market during forecast period.
 

The U.S. helicobacter pylori testing is anticipated to register significant growth during projected period. Rising consciousness about testing options, rapid technological advancements in the field of H. pylori will benefit the overall market evolution in the country. Moreover, the well-established healthcare infrastructure, discovery of technologies, higher diagnosis rate and increasing geriatric population will contribute towards revenue growth. Government organizations such as the Centers for Medicare & Medicaid Services (CMS), U.S. FDA and the Center for Disease Control (CDC) regulates & ensures quality laboratory testing. Presence of such institutions contribute positively to this region’s development. In total, CLIA covers approximately 260,000 laboratory entities. Thus, constant innovation, high-end technology, acquisitions and novel product launches in the U.S. has positively impacted helicobacter pylori testing market growth.
 

Meridian Biosciences is one of the prominent players in stool antigen testing for H. pylori diagnostics market

Meridian Biosciences is one of the leaders in biotechnology, in-vitro diagnostics and tissue-based cancer diagnostics. The company is operating in the industry since 1896 and undertakes various strategic initiatives including new product launch to strengthen its business. Other key players operating in the global H. pylori diagnostic industry include Abbott, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, Quidel Corporation and Thermo Fisher. These companies adopt various policies such as acquisitions, mergers, and geographic expansion to expand business.
 

Recent industry developments:

  • In Feb 2019, Exalenz Bioscience Ltd. announced that the China Food and Drug Administration has permitted Exalenz to initiate marketing and selling its BreathID Hp Lab System for detection of H. pylori bacteria
     
  • In October 2018, DiaSorin and Meridian Bioscience, Inc. strategically collaborated to sell DiaSorin’s FDA-cleared Helicobacter pylori stool antigen test to identify H. pylori for use on its automated LIAISON platform under the Meridian brand name worldwide.
     

The helicobacter pylori testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:

By Test Type

  • Invasive 
  • Histology
  • Rapid Urease Test           
  • HP Culture   
  • Non-invasive 
  • Serologic Test
  • Urea Breath Test
  • Stool Antigen Test

By Method

  • Point of care (POC) test
  • Laboratory based test

By End-use

  • Clinics
  • Hospitals
  • Diagnostic laboratories
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Poland
    • Spain
    • Romania
    • Russia
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Others
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Nigeria
    • Turkey
    • Others

 

Frequently Asked Questions (FAQ) :

Helicobacter pylori is an aerobic, gram-negative bacteria primarily detected in the stomach. It plays a vital role in sustaining the stomach ecosystem.
The point-of-care (POC) segment of the helicobacter pylori testing industry dominates the business with USD 120 million revenue share in 2018.
Rise in prevalence of gastric ulcer and high adoption of non-invasive diagnostics will be key driving factors for the growth of helicobacter pylori testing business worldwide.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X